181 related articles for article (PubMed ID: 18539072)
1. [The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest?].
Pasquier M; Maitrot L; Leperlier F; Dehghani C; Snaifer E; Durnerin IC; Hugues JN
Gynecol Obstet Fertil; 2008 Jun; 36(6):644-9. PubMed ID: 18539072
[TBL] [Abstract][Full Text] [Related]
2. To add GnRH antagonists to controlled ovarian stimulation in management of subfertile couples with IUI may not have additional effect in terms of clinical pregnancy rates.
Kelekci S
Fertil Steril; 2011 Aug; 96(2):e133; author reply e134. PubMed ID: 21669412
[No Abstract] [Full Text] [Related]
3. The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial.
Cantineau AE; Cohlen BJ; Klip H; Heineman MJ;
Hum Reprod; 2011 May; 26(5):1104-11. PubMed ID: 21339196
[TBL] [Abstract][Full Text] [Related]
4. [How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols].
Kol S
Akush Ginekol (Sofiia); 2001; 40(4):36-41. PubMed ID: 11803870
[No Abstract] [Full Text] [Related]
5. Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome.
Bosch E; Escudero E; Crespo J; Simón C; Remohí J; Pellicer A
Fertil Steril; 2005 Nov; 84(5):1529-32. PubMed ID: 16275263
[TBL] [Abstract][Full Text] [Related]
6. [Impact of luteal phase support by human chorionic gonadotropin (hCG) in intrauterine inseminations].
Dupuis S; Dani V; Fatfouta I; Staccini P; Delotte J
Gynecol Obstet Fertil Senol; 2019 Oct; 47(10):739-746. PubMed ID: 31336184
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
8. [Intrauterine insemination: spontaneous or medically-assisted ovulation?].
Massin N; Cédrin-Durnerin I; Hugues JN
Gynecol Obstet Fertil; 2004 Oct; 32(10):898-903. PubMed ID: 15501170
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination.
Li HW; Yeung WS; Lau EY; Ho PC; Ng EH
Fertil Steril; 2010 Nov; 94(6):2177-81. PubMed ID: 20171627
[TBL] [Abstract][Full Text] [Related]
10. [GnRH antagonists in insemination : can we avoid weekends?].
Antoine JM
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S50-2. PubMed ID: 15643690
[TBL] [Abstract][Full Text] [Related]
11. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
12. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
[TBL] [Abstract][Full Text] [Related]
13. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
Orvieto R; Rabinson J; Meltcer S; Gemer O; Anteby EY; Zohav E
Fertil Steril; 2008 Mar; 89(3):736-7. PubMed ID: 17498708
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
Kumbak B; Kahraman S
Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
[TBL] [Abstract][Full Text] [Related]
15. [Natural cycle in vitro fertilization cycle in poor responders].
Reyftmann L; Déchaud H; Loup V; Anahory T; Brunet-Joyeux C; Lacroix N; Hamamah S; Hédon B
Gynecol Obstet Fertil; 2007 Apr; 35(4):352-8. PubMed ID: 17336129
[TBL] [Abstract][Full Text] [Related]
16. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
[TBL] [Abstract][Full Text] [Related]
17. Role of LH in controlled ovarian stimulation.
Wiesak T
Reprod Biol; 2002 Nov; 2(3):215-27. PubMed ID: 14666146
[TBL] [Abstract][Full Text] [Related]
18. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
[TBL] [Abstract][Full Text] [Related]
19. Antral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterility.
Checa MA; Prat M; Carreras R
Fertil Steril; 2010 Aug; 94(3):1105-7. PubMed ID: 20045519
[TBL] [Abstract][Full Text] [Related]
20. Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial.
Eskandar MA
Gynecol Endocrinol; 2007 Oct; 23(10):551-5. PubMed ID: 17891598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
